Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans

Abroad (travel likely)RecruitingPHASE1

Conditions

Major Depression Disorder · Depression

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine,, West Haven, Connecticut, United States
Contact: Study coordinator (Deepak C D'Souza, MD) · deepak.dsouza@yale.edu · 203-932-5711

Study leads

Deepak D'Souza, MD
Principal Investigator
Yale University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression

Depression · Major Depressive Disorder · Major Depression

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression

Major Depression

Abroad (travel likely)RecruitingEARLY_PHASE1

Belmont, United States

Accelerated High-Dose tDCS for Depression

Major Depression · Major Depression Disorders

Abroad (travel likely)Recruiting

Charleston, United States

tDCS: Sleep to Mood in Depression (S2M-D)

Major Depressive Disorder · MDD · Depression

Abroad (travel likely)Recruiting

New York, United States